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Development of a high-throughput screening system 
for identifi cation of novel reagents regulating DNA damage 
in human dermal fi broblasts
Ultraviolet (UV) radiation is a major inducer of skin aging 
and accumulated exposure to UV radiation increases DNA 
damage in skin cells, including dermal fi broblasts. In the 
present study, we developed a novel DNA repair regulating 
material discovery (DREAM) system for the high-through-
put screening and identifi cation of putative materials regu-
lating DNA repair in skin cells. First, we established a modi-
fi ed lentivirus expressing the luciferase and hypoxanthine 
phosphoribosyl transferase (HPRT) genes. Then, human 
dermal fi broblast WS-1 cells were infected with the modi-
fi ed lentivirus and selected with puromycin to establish cells 
that stably expressed luciferase and HPRT (DREAM-F cells). 
The fi rst step in the DREAM protocol was a 96-well-based 
screening procedure, involving the analysis of cell viability 
and luciferase activity aft er pretreatment of DREAM-F cells 
with reagents of interest and post-treatment with UVB ra-
diation, and vice versa. In the second step, we validated cer-
tain eff ective reagents identifi ed in the fi rst step by analyz-
ing the cell cycle, evaluating cell death, and performing 
HPRT-DNA sequencing in DREAM-F cells treated with 
these reagents and UVB. This DREAM system is scalable 
and forms a time-saving high-throughput screening system 
for identifying novel anti-photoaging reagents regulating 
DNA damage in dermal fi broblasts.
Keywords: human dermal fi broblasts, DNA damage, high - 
-throughput screening, aging 
The skin is the largest organ and forms the outermost layer of the human body. There-
fore, the skin is more easily exposed to toxic environmental agents, particularly ultraviolet 
(UV) radiation, than are other tissues, except for the eyes. Human skin consists of the epi-
dermis, dermis and hypodermis. The most abundant cells in the dermis layer are human 
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collagen synthesis. However, chronic and continuous exposure to UV radiation leads to 
upregulation of matrix metalloproteinases (MMPs), collagen degradation and wrinkle for-
mation, which are the main features of skin aging (1, 2). In addition, UV radiation generates 
reactive oxygen species and DNA damage that induce cellular senescence and apoptosis in 
HDFs (3). Furthermore, exposure to UV radiation is an important causative factor for skin 
diseases, such as photodermatoses, actinic keratosis and skin cancer (3). However, UV-in-
duced skin aging is not an inevitable natural consequence, but is due to extracellular 
factors; in other words, the aging process is controllable by avoidance of UV irradiation 
(4).
Accumulating evidence indicates that the application of a chemical sunscreen, a 
commonly known as sun creams with an adequate sun protection factor (SPF), is able to 
decrease UV-induced DNA damage, such as the formation of pyrimidine dimers, in hu-
man skin (5, 6). However, the eff ectiveness of a sunscreen has been challenged by new 
research. Notably, sunscreen is only eff ective in preventing UV-induced DNA damage 
when used regularly (7, 8). Furthermore, a recent study demonstrated that sunscreens 
with superior UVA protection and UVB SPF 50 delayed the onset of UV radiation-in-
duced melanoma skin cancer, but provided only partial protection, indicating that UV 
light can sneak past the sunscreen and cause long-term DNA damage, even in case of an 
SPF 50 sunscreen (9). These results indicate that sunscreen-mediated UV blockage is not 
100 % protective against UV radiation, and has no lasting UV-protective eff ect. Sunscreen 
exerts only a physical protective eff ect within its given SPF time, not a biological protective 
eff ect against UV radiation in human skin. 
Thus, identifi cation of novel reagents exerting a biological UV protective eff ect in skin 
cells is an important future strategy for preventing UV-induced skin aging. To this end, we 
have developed a novel large-scale screening system, the DNA repair regulating material 
discovery (DREAM) system. This system facilitates the high-throughput identifi cation of 
materials that eff ectively protect against and/or repair UV-induced DNA damage in HDFs. 
EXPERIMENTAL
Cells and reagents
Normal human dermal fi broblasts (NHDFs) were purchased from Lonza (Switzer-
land) and human dermal fi broblast WS1 cells were purchased from the CLS Cell Line 
Service (Germany). The cells were maintained in Dulbecco’s modifi ed Eagle’s medium 
(DMEM, Gibco, Life Technologies, USA) containing 10 % fetal bovine serum (FBS, Sigma-
Aldrich, USA) at 37 °C and 5 % CO2 in a humidifi ed chamber. To analyze cytotoxicity and 
luciferase activity, 5 × 103 cells were seeded into a 96-well culture plate and grown. Titrated 
extract of Centella asiatica (TECA) is a reconstituted mixture comprising asiatic acid, madecas-
sic acid, asiaticoside and madecassoside in 4:4:3 ratio and was purchased from Bayer Health-
Care (Germany). Dimethylsulfoxide (DMSO), epigallocatechin gallate (EGCG), quercetin 
and caff eic acid were purchased from Sigma-Aldrich. 
Recombinant lentivirus construction
The open reading frame (ORF) sequence of the fi refl y luciferase gene in the pGL3 lu-
ciferase reporter vector (Promega, USA) was amplifi ed by polymerase chain reaction (PCR) 
333
S. Bae et al.: Development of a high-throughput screening system for identifi cation of novel reagents regulating DNA damage in 
human dermal fi broblasts, Acta Pharm. 65 (2015) 331–341.
 
using the following primers adapted to the BamHI site and sensor sequence (forward 
primer: 5’-CGGATCCAGCCAGAGCCAGTTTTTGATGGAAGACGC3’), and the EcoRI site 
(reverse primer: 5’-GGAATTCCTTACACGGCGATC-3’). The PCR product was cloned into 
the Lenti-HT vector. The ORF sequence of hypoxanthine phosphoribosyl-transferase 
(HPRT) was amplifi ed by PCR using the following primers adapted to the BamHI site: 
forward, 5’-CGGATCCACCATGGCGACCCGCAG-3’ and reverse, 5’-CGGATCCGGCTTT-
GTATTTTGC-3’. The resulting HPRT PCR product was cloned into the Lenti-HT-luciferase 
vector. To generate recombinant lentivirus containing the luciferase and HPRT genes, em-
bryonic kidney 293T cells were co-transfected with the Lenti-HT-luciferase/HPRT lentivi-
ral transfer vector, pCMV-dR8.2 (Addgene, USA), and the pCMV-VSV-G plasmid (Add-
gene), and then the transfected cells were incubated for 48 h. Aft er 48 h of transfection, the 
medium, which contained recombinant lentivirus particles, was collected and used to 
infect WS1 cells. Infected WS1 cells were selected by incubation with DMEM medium 
containing puromycin (1 μg mL–1). The selected WS1 cells were further infected with len-
tivirus expressing β-galactosidase (β-gal), which was previously generated by transfection 
with pSMPUM-MNDnLacZ vector (Cell Biolabs, Inc., San Diego, CA, USA), pCMV-dR8.2, 
and pCMV-VSV-G plasmid. The infected WS1 cells expressing luciferase and β-gal were 
inoculated into a 96-well culture plate and then subjected to puromycin selection to pro-
duce single clones. Luciferase expression in each individual clone was detected via a lumi-
nometer and the expression levels were analyzed by comparison with the expression level 
of β-gal. In the present study, the clone with the highest luciferase expression was selected 
and named DREAM-F cells. 
UV irradiation
Before exposure to UVB radiation, NHDFs and DREAM-F cells were seeded in 96-well 
and 60-mm culture plates and cultured in the growth media overnight. When more than 
70 % confl uent, the cells were pretreated with control DMSO, TECA or EGCG for 6 h. Aft er 
pretreatment, the cell media were washed out with PBS twice, and then the cells were 
exposed to 100 mJ cm–2 UVB without covering the cell culture plates, so that the UVB light 
was not fi ltered. The irradiated cells were then cultured for an additional 24 h in the 
growth media. In the post-treatment experiment, cells were fi rst irradiated with UVB and 
then treated with the reagents for 24 h. 
Cytotoxicity assay
The cytotoxic and UVB-protective eff ects of each reagent on dermal fi broblast cells 
were analyzed using a water-soluble tetrazolium salt (WST-1) assay (EZ-Cytox cell viabil-
ity assay kit, Itsbio, Korea). We did not use the MTT assay, because MTT gets converted 
into a water-insoluble formazan and therefore requires an extra step of media suction and 
DMSO addition to evaluate cell viability, oft en resulting in higher error rates. However, 
WST is converted to a water-soluble formazan and there is no need of this extra step. Cells 
were seeded into a 96-well culture plate and pretreated with various concentrations (as 
indicated) of the reagents in one group and 100 mJ cm–2 UVB radiation in another group. 
Aft er pretreatment with reagents for 24 h, cells were irradiated with UVB radiation and 
cultured for an additional 24 h. Aft er pretreatment with UVB radiation, cells were treated 
with the indicated reagent concentrations for 24 h. Aft er treatment, 10 μL of the WST-1 kit 
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solution was added to cells seeded in a 96-well culture plate and incubated at 37 °C for 0.5 h. 
Cell viability was determined by measuring the absorbance at 450 nm using an iMark 
microplate reader (Bio-Rad, USA). Three independent experiments were performed and 
the results are presented as the means ± standard deviation. 
 Flow cytometric analysis
Aft er treatment with the reagents and UVB irradiation, the cells were harvested, 
twice washed with cold PBS and suspended with 1 mL of cold 70 % ethanol. Subse-
quently, the cells were fi xed by incubation at –20 °C for 2 h. The cells were then washed 
with cold PBS and resuspended in 0.5 mL of propidium iodide (PI) staining solution (50 
μg mL–1 PI, 0.5 % Triton X-100, both from Sigma-Aldrich, and 100 μg mL–1 RNase in PBS) and 
incubated at 37 °C for 1 h. The cell population in diff erent phases of cell cycle was mea-
sured by evaluating the intensity of fl uorescent PI staining of 10,000 cells using the FL2-
H channel of a FACSCalibur fl ow cytometer (BD Biosciences, USA). 
Luciferase assay
DREAM-F cells were seeded into a 96-well culture plate and cultured for 24 h. Fol-
lowing this, one group was pretreated with the reagents and post-treated with 100 mJ cm–2 
UVB radiation and the other group was fi rst exposed to UVB irradiation and then post-
treated with the reagents. Aft er treatment, the cell medium was subsequently discarded 
and 50 μL of passive lysis buff er (Promega) was added to each well and incubated for 5 
min. Half of the resulting cell lysate from each well was then transferred to a white opaque 
luminometer microtiter plate and mixed with 80 μL of luciferase assay reagent (Promega). 
The luciferase activity of each well was analyzed using a Veritas luminometer (Turner 
Designs, USA). The remaining half of the cell lysate from each well was used to analyze 
β-gal activity using the luminescent β-galactosidase detection kit II (Clontech Laborato-
ries, Inc., USA). The relative luciferase activity was normalized to β-gal activity. The results 
are the averages of three independent experiments. 
Statistical analysis
All results are presented as the mean percentage ± standard deviation (SD) of three 
independent experiments. p-value of < 0.05, as determined by Student’s t-test, was consi-
dered to indicate a statistically signifi cant diff erence.
RESULTS AND DISCUSSION
Construction of lentiviruses containing the luciferase and HPRT genes
UVB radiation spontaneously induces the generation of high levels of cyclobutane 
pyrimidine dimers (CPDs) in genomic DNA. These CPDs inhibit mRNA transcription by 
stalling RNA polymerase II at the CPD sites (10). Furthermore, UVB radiation causes per-
manent mutation-mediated DNA damage, including C  T and CC  TT transition muta-
tions (11). Therefore, UVB-induced CPDs and transition mutations are able to downregu-
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late the expression of certain genes or induce the expression of mutant proteins with 
altered protein activities. Many studies have evaluated the eff ects and mechanisms of UV-
induced DNA damage in skin. Among these, a recent study based on sequencing and 
comparing mutations in the housekeeping gene hypoxanthine phosphoribosyl-transferase 
(HPRT) concluded that not only UVB but also UVA is able to induce CPDs and the C  T 
transition in human skin fi broblasts (12). 
Based on the above results, we aimed to develop a UV-induced DNA damage sensor 
system using human dermal fi broblasts. First, the UV-induced reduction in transcription 
and altered mutant protein level were evaluated using a luciferase system. The luciferase 
assay is a technique with a diverse range of applications in molecular biology and we 
confi rmed that UV irradiation signifi cantly reduced the activity of luciferase in luciferase 
vector-transfected NHDFs (data not shown). Next, to render the luciferase system more 
vulnerable against UV radiation, we inserted sensor sequences (SSs; 5’-AGCCAGAGC-
CAGTTTTTG-3’) upstream of the luciferase ORF sequence. A study by Kreimer-Erlacher 
et al. (13) showed that in CC-containing sequences, the latt er C was more commonly sub-
stituted with T than the former C (CC  CT transition). Therefore, following UV irradia-
tion, a stop codon is likely to be created in the ‘AGCCAG’ sequence in the SS (AGCCAG  
AGCTAG). The sequence of TTTTT in the SS has the potential to develop CPDs following 
UV irradiation. Furthermore, to analyze the exact number of mutations following UV ir-
radiation, the housekeeping gene HPRT was cloned into the N-terminal region of the SS. 
A study of Kappes at al. (12) showed that irradiation with 100, 200 and 400 J m–2 UVB re-
sulted in the generation of roughly 10, 23 and 59 mutations in the HPRT gene in human 
fi broblasts. Therefore, in summary, the HPRT-SS-luciferase fusion sequence was used to 
evaluate the level of UV-induced damage. To generate NHDFs expressing the HPRT-SS-
luciferase protein, we used the lentiviral system, which stably infects dividing and non-
Fig. 1. Vector maps of pLenti-HT-luciferase, the packaging plasmid and the envelope plasmid. LTR-
long terminal repeat sequence, RRE, rev response element; cPPT, central polypurine tract; PCMV, 
cmv promoter; MCS, multiple cloning sites; IRES, internal ribosome entry site; PuroR, puromycin 
resistant gene; WPRE, woodchuck hepatitis virus post-transcription regulatory element; VSV-G, ve-
sicular stomatitis virus GP; PolyA, poly-A sequence.
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dividing human cells. As shown in Fig. 1, the HPRT-SS-luciferase sequence was inserted 
between the CMV promoter and the IRES sequence in the pLenti-HT vector. The ORF re-
gion of fi refl y luciferase was cloned into the EcoRI site of pLenti-HT. pCMV-VSV-G is a 
VSV-G coding plasmid, which allowed the production of viral particles. pCMV-dR8.2 is a 
packaging plasmid, which encodes 4 genes, including Gag, Pol, Rev, and Tat. Subsequent-
ly, lentivirus particles were generated by transfecting 293T cells with the recombinant 
pLenti-HT, packaging vector pCMV-dR8.2 and pCMV-VSV-G. Aft er 48 h of transfection, 
recombinant lentivirus particles were collected by fi ltration (Figs. 2a,b).
Generation of HPRT-SS-luciferase-expressing DREAM-F cells
Aft er the generation of lentivirus encoding HPRT-SS-luciferase from 293T cells (Fig. 
2a), human dermal fi broblast WS1 cells were infected with the recombinant lentivirus for 
48 h. To select infected cells, culture medium was replaced with selection medium, con-
taining puromycin, and the cells were further incubated for 1 week. It is commonly 
known that lentivirus randomly integrates within the genome; hence, the expression 
Fig. 2. Schematic diagram of luciferase-expressing lentivirus production and DREAM-F cell genera-
tion: a) Luciferase-expressing lentiviruses were produced by transfecting 293T cells with the pLenti-
HT-HPRT-SS-luciferase, pCMV-VSV-G and pCMV-dR8.2 plasmids; b) Establishment of luciferase-
fused WS1 cells (DREAM-F cells); c) Identifi cation of a cell clone with the highest expression level of 
luciferase. The results are expressed as the means ± SD from three separate experiments; NC – nega-
tive control. Signifi cant diff erence compared with control WS1 cells (*p < 0.05). 
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level of the HPRT- -SS-luciferase fusion gene varied in individual cells. Therefore, we con-
ducted an additional selection process to obtain single clonal cells. One or two numbers of 
infected cells were seeded into individual wells of a 96-well plate and grown in the selec-
tion medium for 1 week. Each of the cell colonies was continuously grown to 80 % confl u-
ence in a 6-well culture plate (Fig. 2b). Aft er single cell selection, we analyzed the level of 
luciferase activity, and selected the highest expressed clone, which we named DREAM-F 
cells (Fig. 2c). 
Establishing a system to identify novel reagents regulating UVB-induced DNA damage 
using DREAM-F cells
The fi rst step was to determine appropriate experimental concentrations, in terms of 
low cytotoxicity, of the candidate reagents. DREAM-F cells were seeded into a 96-well 
culture plate and treated with 4 or 5 concentrations of each reagent. Aft er 24 h of treatment, 
the level of cytotoxicity was evaluated by the WST-1 assay. Aft er evaluating the cytotoxic-
ity of each reagent, its UV-protective or UV-induced damage-repairing eff ects were ana-
lyzed using DREAM-F cells. To evaluate the UV protective eff ect, DREAM-F cells were 
pretreated with low-cytotoxicity concentrations of the candidate reagents for 6 h and then 
exposed to 100 mJ cm–2 UVB light. Aft er 24 h of further incubation, cell viability and lucife-
rase activity were analyzed using the WST-1 and luciferase assays. To evaluate UV-induced 
damage repair, cells were irradiated with UVB and postt reated with the candidate re-
agents. We thereby identifi ed candidate reagents showing protective or repair eff ects. This 
screening system is elucidated in Fig. 3a. 
To validate this system, we used four types of phytochemicals: titrated extract of Cen-
tella asiatica (TECA), epigallocatechin gallate (EGCG), caff eic acid (CA), and quercetin (QC). 
Our group recently found that TECA exerts a UV-protective eff ect in human dermal fi bro-
blasts by downregulating UV-induced cellular and DNA damage (14). Furthermore, it was 
demonstrated that EGCG has a UV-protective eff ect in human dermal fi broblasts (15). CA 
and QC are known to exert inhibitory eff ects against UV-induced oxidative stress (16, 17). 
As shown in Fig. 3b, relatively high concentrations of TECA and EGCG exhibited cytotox-
icity in DREAM-F cells, whereas CA and QC showed no cytotoxicity. Interestingly, UV-
protective and UV-induced cellular damage repair eff ects were only present in TECA- and 
EGCG-treated DREAM-F cells (Fig. 3c). Further experiments showed that TECA and EGCG 
inhibited UV-induced loss of luciferase activity in DREAM-F cells (Fig. 3d), indicating that 
these two reagents have a UV-protective and UV-induced DNA damage repair eff ects in 
human dermal fi broblasts. Our previous study demonstrated that TECA inhibits UVB-
induced cellular toxicity; however, we also found that TECA directly inhibited UVB-in-
duced DNA damage using our DREAM system. Other reports showed that EGCG reduced 
UVB-induced oxidative DNA damage in living skin equivalents (18). Although previous 
reports demonstrated CA- and QC-mediated anti-oxidative eff ects in hairless mice and 
lymphocytes, these eff ects might be cell-specifi c or may not be directly involved in the loss 
of cell viability mediated by UV radiation (16, 17). Overall, our results indicate that the 
DREAM system is useful for the identifi cation of novel reagents regulating UV-induced 
DNA damage in human dermal fi broblasts.
Other potential applications of the DREAM system
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UV irradiation spontaneously causes DNA damage, causing accumulation of reactive 
oxygen species (ROS) and cell cycle arrest in skin cells (19). If such damage is not repaired 
or inhibited, skin cells undergo irreversible apoptosis-mediated cell death (19). Although 
the main purpose of the DREAM system was to identify novel reagents regulating UV-
induced DNA damage in human dermal fi broblasts, the identifi ed reagents could also be 
associated with protection or regeneration in cells that have undergone UV-mediated 
damage. Furthermore, our fi rst prototype of the DREAM system (as shown in Fig. 3a) was 
able to determine the level of UV-induced DNA damage by the luciferase assay. However, 
the exact number of UV-induced DNA mutations could not be counted. Therefore, several 
reagents identifi ed using the fi rst DREAM screening were then used in the second DREAM 
system to evaluate changes in the cell cycle phase and DNA mutations aft er UV irradia-
tion. As shown in Fig. 4, DREAM-F cells were seeded into 60-cm or 6-well culture plates 
and treated with the identifi ed reagents before or aft er UV irradiation. Aft er 24 h of incuba-
Fig. 3. Schematic diagram and confi rmation of the fi rst DREAM screening system: a) Strategy for the 
identifi cation of putative reagents showing protective eff ect against UVB radiation and regulatory 
eff ect on UVB-induced loss of luciferase activity; b) Evaluation of cytotoxicities for TECA, EGCG, CA 
and QC; c) Evaluation of the protective eff ect against UVB-induced loss of cell viability. Signifi cant 
diff erence compared to UVB-irradiated DREAM-F cells (*p < 0.05); d) Evaluation of protective eff ect 
against UVB-induced downregulation of luciferase activity (mean ± SD, n = 3). Signifi cant diff erence 
compared to control WS1 cells and UVB-irradiated DREAM-F cells (*p < 0.05).
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tion, cells were gathered and stained with fl uorescent propidium iodide. The stained cells 
were subjected to cell cycle analysis using fl ow cytometry. To analyze the number of muta-
tions, the reagents and UV-treated cells were incubated for 96 h in growth media and 
subjected to total RNA purifi cation and cDNA synthesis. The fusion gene of HPRT-SS-lu-
ciferase was analyzed by cDNA sequencing. We confi rmed that TECA and EGCG-treat-
ment decreased UV-induced cell accumulation in the sub-G1 phase (apoptosis phase), in-
dicating that these reagents block UV-induced cell death in human dermal fi broblasts (14, 
15). Changes in the number of mutations aft er treatment of DREAM-F cells with each re-
agent and UV irradiation are currently under investigation. 
CONCLUSIONS
Our aim was to develop a large-scale and high-throughput screening system for iden-
tifying novel reagents that protect against or repair UV-induced DNA damage in human 
dermal fi broblasts. For this purpose, we used a 96-well-based screening system using 
DREAM-F cells. In conclusion, our study demonstrates that the hybrid luciferase gene can 
be used for evaluating the level of DNA damage caused by UV irradiation in human dermal 
fi broblasts. Furthermore, we generated DREAM-F cells using lentiviruses. This hybrid cell 
off ers a large-scale and high-throughput screening system for novel anti-aging reagents 
Fig. 4. Schematic diagram of the second DREAM screening system. Aft er DREAM-F cells were exposed 
to UVB radiation or post-treated with a reagent, cells were gathered and subjected to PI-staining-based 
FACS analysis and mutation analysis through HPRT cDNA synthesis and DNA sequencing.
340
S. Bae et al.: Development of a high-throughput screening system for identifi cation of novel reagents regulating DNA damage in 
human dermal fi broblasts, Acta Pharm. 65 (2015) 331–341.
 
under false-positive-free conditions. Also, we validated this DREAM system using TECA, 
EGCG, CA, QC reagents, and found that TECA and EGCG are novel phytochemicals show-
ing a direct inhibitory eff ect on UV-induced DNA damage in dermal fi broblasts. Therefore, 
we believe that the DREAM system is appropriate for identifi cation of novel pharmaceutical 
reagents showing anti-photoaging or anti-photocarcinogenesis in the future. 
Abbreviations, acronyms and symbols. – DREAM system – DNA repair regulating mate-
rial discovery system, HPRT – hypoxanthine phosphoribosyl transferase, HDFs – human 
dermal fi broblasts, MMPs – matrix metalloproteinase, SPF – sun protection factor, CPDs 
– cyclobutane pyrimidine dimers, TECA – titrated extract of Centella asiatica, EGCG – 
epigallocatechin gallate, CA – caff eic acid; QC – quercetin.
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